Inventor · disambiguated record
Joe Salas
Also filed as: SALAS JOE
9 granted patents·12 pending applications·19 citations·filing 2011–2022
84Inventor score
Top patents by PatentIndex Score
21 records- 0181US10927362B2Processable single chain molecules and polypeptides made using sameBIOVERATIV THERAPEUTICS INC·Filed 2017·Granted Feb 23, 2021·1 cites·14 claims
- 0281US10875924B2Anti-GPIIB/IIIA antibodies and uses thereofBIOGEN MA INC·Filed 2015·Granted Dec 29, 2020·3 cites·16 claims
- 0381US10364288B2Anti-GPIIB/IIIA antibodies or uses thereofBIOGEN MA INC·Filed 2014·Granted Jul 30, 2019·3 cites·8 claims
- 0481US10287564B2Procoagulant compoundsBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted May 14, 2019·5 cites·11 claims
- 0581US9856468B2Processable single chain molecules and polypeptides made using sameSALAS JOE·Filed 2011·Granted Jan 2, 2018·7 cites·21 claims
- 0675US2021355473A1Chimeric clotting factorsBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0773US2021292729A1Processable single chain molecules and polypeptides made using sameBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0872US2022213200A1Anti-gpiib/iiia antibodies or uses thereofBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 0968US2022135959A1Chimeric clotting factorsBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1067US2022089745A1ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIESBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 1166US11261437B2Procoagulant compoundsBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Mar 1, 2022·0 cites·12 claims
- 1266US2020102391A1Anti-gpiib/iiia antibodies or uses thereofBIOGEN MA INC·Filed 2019·Application pending·0 cites
- 1365US11168316B2Chimeric clotting factorsBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Nov 9, 2021·0 cites·12 claims
- 1464US2020354459A1ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIESBIOGEN MA INC·Filed 2019·Application pending·0 cites
- 1563US10968442B2Chimeric clotting factorsBIOVERATIV THERAPEUTICS INC·Filed 2016·Granted Apr 6, 2021·0 cites·23 claims
- 1657US2022243189A1Procoagulant compoundsBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1757US2021246212A1Anti-gpiib/iiia antibodies and uses thereofBIOGEN MA INC·Filed 2020·Application pending·0 cites
- 1852US10202595B2Chimeric clotting factorsBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Feb 12, 2019·0 cites·14 claims
- 1952US2017342152A1ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIESBIOGEN MA INC·Filed 2015·Application pending·0 cites
- 2048US2022233650A1Recombinant factor viii-fc for treating hemophilia and low bone mineral densityBIOVERATIV THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2147US2016115467A1Chimeric fvii-xten molecules and uses thereofBIOGEN MA INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joe Salas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →